Monika Dufmats

842 total citations
13 papers, 619 citations indexed

About

Monika Dufmats is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Monika Dufmats has authored 13 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Monika Dufmats's work include Breast Cancer Treatment Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Monika Dufmats is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Genetic factors in colorectal cancer (3 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). Monika Dufmats collaborates with scholars based in Sweden. Monika Dufmats's co-authors include Eberhard Varenhorst, Gabriel Sandblom, Bo Nordenskjöld, Christer Sederholm, Karl Kölbeck, Kristina Lamberg, Ronny Westberg, Gunnar Hillerdal, Olle Stål and Sten Wingren and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Monika Dufmats

13 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Dufmats Sweden 12 375 231 198 125 86 13 619
R. Knight United Kingdom 15 367 1.0× 134 0.6× 275 1.4× 66 0.5× 118 1.4× 32 642
Janice F. Eakle United States 9 565 1.5× 345 1.5× 265 1.3× 246 2.0× 76 0.9× 22 805
Hammouda Boussen Tunisia 12 345 0.9× 167 0.7× 147 0.7× 187 1.5× 73 0.8× 57 708
Bianca Lederer Germany 13 415 1.1× 119 0.5× 348 1.8× 120 1.0× 147 1.7× 39 646
Annamaria Guazzi Italy 15 311 0.8× 215 0.9× 168 0.8× 144 1.2× 81 0.9× 35 597
Renzo Barbazza Italy 16 314 0.8× 238 1.0× 103 0.5× 142 1.1× 153 1.8× 37 668
Gennaro Limite Italy 11 392 1.0× 80 0.3× 320 1.6× 146 1.2× 119 1.4× 32 674
I. E. Smith United Kingdom 12 503 1.3× 136 0.6× 403 2.0× 217 1.7× 137 1.6× 27 848
Kazunori Nishida Japan 13 350 0.9× 319 1.4× 97 0.5× 230 1.8× 83 1.0× 22 647
Massimo Rinaldo Italy 15 307 0.8× 104 0.5× 299 1.5× 98 0.8× 147 1.7× 29 690

Countries citing papers authored by Monika Dufmats

Since Specialization
Citations

This map shows the geographic impact of Monika Dufmats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Dufmats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Dufmats more than expected).

Fields of papers citing papers by Monika Dufmats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Dufmats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Dufmats. The network helps show where Monika Dufmats may publish in the future.

Co-authorship network of co-authors of Monika Dufmats

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Dufmats. A scholar is included among the top collaborators of Monika Dufmats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Dufmats. Monika Dufmats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sederholm, Christer, Gunnar Hillerdal, Kristina Lamberg, et al.. (2005). Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group. Journal of Clinical Oncology. 23(33). 8380–8388. 146 indexed citations
2.
Lindholm, Christer, Monika Dufmats, Johan Hansson, et al.. (2004). Invasive cutaneous malignant melanoma in Sweden, 1990–1999. Cancer. 101(9). 2067–2078. 83 indexed citations
3.
Dufmats, Monika, et al.. (2004). Atopic manifestations are more common in patients with Crohn disease than in the general population. Scandinavian Journal of Gastroenterology. 39(8). 731–736. 25 indexed citations
4.
Rydén, Lisa, Gunilla Chebil, Monika Dufmats, et al.. (2004). Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up. European Journal of Cancer. 41(2). 256–264. 85 indexed citations
5.
Tejler, Göran, et al.. (2004). Survival after treatment for breast cancer in a geographically defined population. British journal of surgery. 91(10). 1307–1312. 21 indexed citations
6.
Sandblom, Gabriel, Monika Dufmats, Mats J. Olsson, & Eberhard Varenhorst. (2003). Validity of a Population-Based Cancer Register in Sweden An Assessment of Data Reproducibility in the South-East Region Prostate Cancer Register. Scandinavian Journal of Urology and Nephrology. 37(2). 112–119. 42 indexed citations
7.
Sandblom, Gabriel, et al.. (2000). Prostate carcinoma trends in three counties in Sweden 1987-1996. Cancer. 88(6). 1445–1453. 28 indexed citations
8.
Sandblom, Gabriel, Monika Dufmats, & Eberhard Varenhorst. (2000). Long-term survival in a swedish population-based cohort of men with prostate cancer. Urology. 56(3). 442–447. 39 indexed citations
9.
Gentile, Marco, Karen Ege Olsen, Monika Dufmats, & Sten Wingren. (1999). Frequent allelic losses at 11q24.1–q25 in young women with breast cancer: association with poor survival. British Journal of Cancer. 80(5-6). 843–849. 27 indexed citations
10.
Nordenskjöld, Bo, et al.. (1998). K-ras mutations in colorectal adenocarcinomas and neighbouring transitional mucosa. European Journal of Cancer. 34(13). 2053–2057. 19 indexed citations
11.
Sandblom, Gabriel, et al.. (1997). [Decreasing number of orchiectomies in prostatic cancer. Results of 9-year registration of the disease are reviewed].. PubMed. 94(44). 3966–8, 3971. 1 indexed citations
12.
Stål, Olle, Lambert Skoog, Lars Erik Rutqvist, et al.. (1994). S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer. British Journal of Cancer. 70(6). 1258–1262. 49 indexed citations
13.
Stål, Olle, Monika Dufmats, Thomas Hatschek, et al.. (1993). S-phase fraction is a prognostic factor in stage I breast carcinoma.. Journal of Clinical Oncology. 11(9). 1717–1722. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Knight Breakdown of academic impact, for papers by Janice F. Eakle Breakdown of academic impact, for papers by Hammouda Boussen Breakdown of academic impact, for papers by Bianca Lederer Breakdown of academic impact, for papers by Annamaria Guazzi Breakdown of academic impact, for papers by Renzo Barbazza Breakdown of academic impact, for papers by Gennaro Limite Breakdown of academic impact, for papers by I. E. Smith Breakdown of academic impact, for papers by Kazunori Nishida Breakdown of academic impact, for papers by Massimo Rinaldo
Rankless by CCL
2026